Thus, (R)-7 [(R)-AS-1] may be considered asthe first-in-class small-molecule PAM of EAAT2 with potential forfurther preclinical and clinical development in epilepsy and possiblyother CNS disorders. This evidence concerns the gene SLC1A2 and central nervous system disorder.